search
Back to results

Measurement of the Electromechanical Window to Improve the Diagnosis of Congenital Long QT Syndrome (FEMQT)

Primary Purpose

Long QT Syndrome

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
ECG coupled to phonocardiography
Sponsored by
University Hospital, Bordeaux
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Long QT Syndrome focused on measuring Long QT syndrome, Electromechanical window, Phonocardiography

Eligibility Criteria

12 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Propositus patients with genetically proven LQTS and their relatives,
  • Patients of both sexes aged 12 and over,
  • Free, informed and written consent of the patient and the two holders of parental authority for minors.

Exclusion Criteria:

  • Inability to consent,
  • Person deprived of liberty by judicial or administrative decision,
  • Majors subject to a legal protection measure,
  • Person participating in another research including an exclusion period still in progress,
  • Severely impaired physical and / or psychological health, which, according to the investigator, may affect the participant's compliance with the study.

Sites / Locations

  • Nantes University Hospital
  • Bordeaux University HospitalRecruiting
  • La Réunion University HospitalRecruiting
  • Toulouse University HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Prospective FEMQT Group

Arm Description

Propositus patients with genetically proven LQTS and their relatives

Outcomes

Primary Outcome Measures

Negative predictive value (NPV) obtained by the two methods of diagnosis
The NPV is measured in percentage. The NPV of LQTS diagnosis obtained by phonocardiographic method (measurement of the EMW) and the NPV obtained by standard ECG method (QT measurement prolongation) will be compared.

Secondary Outcome Measures

Values of sensitivity obtained by the two methods of diagnosis
Value of sensitivity is measured in percentage. The values of sensitivity of EMW and standard ECG will be compared.
Values of specificity obtained by the two methods of diagnosis
Value of specificity is measured in percentage. The values of specificity of EMW and standard ECG will be compared.
Positive predictive values obtained by the two methods of diagnosis
Positive predictive value is measured in percentage. Positive predictive values of EMW and standard ECG will be compared.
Area Under the Curves (AUC) obtained by the two methods of diagnosis
The AUC obtained by Receiver Operating Characteristic (ROC) analyses is measured by a value between 0 and 1. The AUC obtained by ROC of EMW and standard ECG will be compared.

Full Information

First Posted
March 27, 2020
Last Updated
February 21, 2022
Sponsor
University Hospital, Bordeaux
search

1. Study Identification

Unique Protocol Identification Number
NCT04328376
Brief Title
Measurement of the Electromechanical Window to Improve the Diagnosis of Congenital Long QT Syndrome
Acronym
FEMQT
Official Title
Measurement of the Electromechanical Window to Improve the Diagnosis of Congenital Long QT Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Recruiting
Study Start Date
August 28, 2020 (Actual)
Primary Completion Date
August 28, 2023 (Anticipated)
Study Completion Date
August 28, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Bordeaux

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this research is to prospectively evaluate the performance of the electromechanical window according to a phonographic method, as a mean of diagnosis of long QT syndrome, and to compare its performance with routine tests used.
Detailed Description
Familial long QT syndrome (LQTS) is a hereditary cardiac disorder in which most affected family members have delayed ventricular repolarization manifest on the electrocardiogram (ECG) as QT prolongation. This disease is associated with an increased propensity to palpitations, syncope, polymorphous ventricular tachycardia and sudden arrhythmic death. The diagnosis relies mostly on resting ECG findings and on genetic testing. In clinical practice however, this diagnosis is complicated by 2 main reasons: 1) a significant overlap in ECG findings between healthy and diseased individuals and 2) a frequent identification of genetic variants of unknown significance. Recent studies have suggested that echocardiographic measurement of the electromechanical window (EMW - the delay between the end of mechanical contraction and electrical activation of the heart) has better performance in the diagnosis of LQTS. The echocardiographic technique is however too complicated for routine clinical use. Preliminary work conducted at the University Hospital of Bordeaux and at the University Hospital of Reunion Island has demonstrated that a phonocardiographic approach leads to similar results with an improved feasibility and a good reproducibility.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Long QT Syndrome
Keywords
Long QT syndrome, Electromechanical window, Phonocardiography

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
224 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Prospective FEMQT Group
Arm Type
Experimental
Arm Description
Propositus patients with genetically proven LQTS and their relatives
Intervention Type
Diagnostic Test
Intervention Name(s)
ECG coupled to phonocardiography
Intervention Description
A standard ECG is recorded along with a phonocardiographic recording. The phonocardiographic recording is obtained by using a specific electronic stethoscope plugged into the auxiliary port of the ECG machine. The recording takes less than 30 seconds. The two recording methods are concomitant. QT interval is measured on the ECG recording, EMW is measured with ECG coupled to phonocardiography.
Primary Outcome Measure Information:
Title
Negative predictive value (NPV) obtained by the two methods of diagnosis
Description
The NPV is measured in percentage. The NPV of LQTS diagnosis obtained by phonocardiographic method (measurement of the EMW) and the NPV obtained by standard ECG method (QT measurement prolongation) will be compared.
Time Frame
Day 1
Secondary Outcome Measure Information:
Title
Values of sensitivity obtained by the two methods of diagnosis
Description
Value of sensitivity is measured in percentage. The values of sensitivity of EMW and standard ECG will be compared.
Time Frame
Day 1
Title
Values of specificity obtained by the two methods of diagnosis
Description
Value of specificity is measured in percentage. The values of specificity of EMW and standard ECG will be compared.
Time Frame
Day 1
Title
Positive predictive values obtained by the two methods of diagnosis
Description
Positive predictive value is measured in percentage. Positive predictive values of EMW and standard ECG will be compared.
Time Frame
Day 1
Title
Area Under the Curves (AUC) obtained by the two methods of diagnosis
Description
The AUC obtained by Receiver Operating Characteristic (ROC) analyses is measured by a value between 0 and 1. The AUC obtained by ROC of EMW and standard ECG will be compared.
Time Frame
Day 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Propositus patients with genetically proven LQTS and their relatives, Patients of both sexes aged 12 and over, Free, informed and written consent of the patient and the two holders of parental authority for minors. Exclusion Criteria: Inability to consent, Person deprived of liberty by judicial or administrative decision, Majors subject to a legal protection measure, Person participating in another research including an exclusion period still in progress, Severely impaired physical and / or psychological health, which, according to the investigator, may affect the participant's compliance with the study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Josselin DUCHATEAU, MD
Phone
(0)5 57 65 64 01
Ext
+33
Email
josselin.duchateau@chu-bordeaux.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Carine LOPEZ
Phone
(0)5 24 54 91 17
Ext
+33
Email
carine.lopez@chu-bordeaux.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Josselin DUCHATEAU, MD
Organizational Affiliation
University Hospital, Bordeaux
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nantes University Hospital
City
Nantes
ZIP/Postal Code
44093
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vincent PROBST, MD PhD
Phone
(0)2 40 16 52 79
Ext
+33
Email
vincent.probst@chu-nantes.fr
First Name & Middle Initial & Last Name & Degree
Vincent PROBST, MD PhD
Facility Name
Bordeaux University Hospital
City
Pessac
ZIP/Postal Code
33604
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Josselin DUCHATEAU, MD
Phone
(0)5 57 65 64 01
Ext
+33
Email
josselin.duchateau@chu-bordeaux.fr
First Name & Middle Initial & Last Name & Degree
Carine LOPEZ
Phone
(0)5 24 54 91 17
Ext
+33
Email
carine.lopez@chu-bordeaux.fr
First Name & Middle Initial & Last Name & Degree
Josselin DUCHATEAU, MD
First Name & Middle Initial & Last Name & Degree
Frédéric SACHER, MD, PhD
First Name & Middle Initial & Last Name & Degree
Romain TIXIER, MD
Facility Name
La Réunion University Hospital
City
Saint-Pierre
ZIP/Postal Code
97410
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maxime CHURET, MD
Phone
02 62 35 91 53
Ext
+33
Email
maxime.churet@chu-reunion.fr
First Name & Middle Initial & Last Name & Degree
Maxime CHURET, MD
First Name & Middle Initial & Last Name & Degree
Olivier GEOFFROY, MD
Facility Name
Toulouse University Hospital
City
Toulouse
ZIP/Postal Code
31400
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Philippe MAURY, MD PhD
Phone
(0)5 61 32 34 70
Ext
+33
Email
maury.p@chu-toulouse.fr
First Name & Middle Initial & Last Name & Degree
jean-Philippe MAURY, MD PhD
First Name & Middle Initial & Last Name & Degree
Anne ROLLIN, MD

12. IPD Sharing Statement

Learn more about this trial

Measurement of the Electromechanical Window to Improve the Diagnosis of Congenital Long QT Syndrome

We'll reach out to this number within 24 hrs